Changing The Face Of Cancer Podcast

Bringing together voices within the field of oncology to support and inform our shared mission: the best possible care for patients with cancer.

[Changing The Face Of Cancer Podcast @CTFOC_Podcast]

We're back with our brand new Summit Series!

Hosting the biggest names in oncology for discussions revolutionizing global cancer care, we’ll get you up to speed with trending clinical topics and discuss where more can be done to transform approaches.

https://t.co/9cHx0paxET

[Changing The Face Of Cancer Podcast @CTFOC_Podcast]

Focusing on #scalpcooling for metastatic patients - @esalehiDNP is heading up a clinical trial @DanaFarber.

The study is hopeful of providing real insight into #scalpcooling efficacy rates with sacituzumab govitecan, #Enhertu, and eribulin.

Listen: https://t.co/CxHJsZ3HoY

[Changing The Face Of Cancer Podcast @CTFOC_Podcast]

Enrolling 30 women on taxane-based chemotherapy, the @MontefioreEinstein trial is seeing promising results and is hopeful in starting to improve #scalpcooling efficacy with previously under-researched population.

Find out more: https://t.co/uWC2s0hkZb

[Scalp Cooling Summit @ScalpCoolSummit]

Did you know #scalpcooling encourages stronger and faster hair regrowth?

Summarising her discussion with @RichPaxman, this Whitepaper focuses on the impact regrowth has had on Dr. Bajpai's patients in India.

Download all Whitepapers, here: https://t.co/piumrCscD5

[Changing The Face Of Cancer Podcast @CTFOC_Podcast]

Drug sequencing has been hypothesized to have an impact on #scalpcooling outcomes.

The experts proposed that administering Taxanes first means the patient and clinician are experienced at a good cap fit – ready for the harsher Anthracycline cycles.

https://t.co/89Hv6cNTJe

[Changing The Face Of Cancer Podcast @CTFOC_Podcast]

The experts discuss reducing the number of “Me Too” trials in #scalpcooling to improve efficacy.

Patients of color, with metastatic disease, and other solid tumor patients, not just breast, should be included when planning clinical trials going forward.

https://t.co/89Hv6cNlTG

[Changing The Face Of Cancer Podcast @CTFOC_Podcast]

To standardize #scalpcooling, Dr. Corina van den Hurk explains the expansion of the Dutch Scalp Cooling Registry.

Sites can self-enroll, compare results with neighboring sites, and reassess their own approaches to #scalpcooling if their efficacy varies.

https://t.co/89Hv6cNlTG

[Changing The Face Of Cancer Podcast @CTFOC_Podcast]

New Episode of #TheSummitSeries!

Dr. Nikolaos Georgopoulos and Dr. Andrew Collett from @HuddersfieldUni discussed their work on developing a topical agent development to enhance the effect of #scalpcooling.

Read the interview: https://t.co/tN3zwITifA

[Changing The Face Of Cancer Podcast @CTFOC_Podcast]

Understanding how #scalpcooling works enables further research into improving outcomes.

@Dr_Nik_G from @HuddersfieldUni discusses the biological mechanisms of #scalpcooling, and how developing a new topical agent could increase efficacy.

Listen: https://t.co/89Hv6cNlTG

[Montefiore Health System @MontefioreNYC]

Dr. Beth McLellan discusses equity in cancer care & our #MECC clinical trial, which is testing whether a #ScalpCooling method can protect Black & Latina women from chemotherapy-induced alopecia. @EinsteinMed @tigerlilycares

Listen to the latest @scalpcooling #CTFOC episode. ⤵️

[Changing The Face Of Cancer Podcast @CTFOC_Podcast]

Previously, #scalpcooling clinical trials have predominately featured white, female, breast cancer patients – and for outcomes to be improved globally, trial characteristics need to be widened.

Hear this week’s panel discuss how this can be actioned: https://t.co/U73an8BmW8

[Changing The Face Of Cancer Podcast @CTFOC_Podcast]

Coming Tomorrow...

@RichPaxman and #scalpcooling experts review trial data and results from the past decade.

They argue that now is the time to focus on underserved populations and improve equitable treatment access.

Catch up on #TheSummitSeries: https://t.co/U73an8BULG

[Changing The Face Of Cancer Podcast @CTFOC_Podcast]

At @MontefioreNYC, a clinical trial is currently underway investigating #scalpcooling efficacy in patients of color.

Headed up by Dr Beth McLellan, the trial is showing promising results hopefully increasing #scalpcooling equity globally.

Listen: https://t.co/B6wv0xHrfF

[Paxman @scalpcooling]

As we work towards increasing our #scalpcooling resources, we want to make sure everyone feels respected and appropriately referred to.

If you are the team handling scalp cooling – what do you feel is the appropriate terminology to describe your role?

[Changing The Face Of Cancer Podcast @CTFOC_Podcast]

Trusting that patients are experts in their own skin and hair, and how to best deal with chemotherapy toxicities associated with these, is the first step to a collaborative care plan.

Listen: https://t.co/U73an8BmW8

[Changing The Face Of Cancer Podcast @CTFOC_Podcast]

Having an ethnocentric approach ensures #scalpcooling protocols are suitable for all patients.

Dr Oyetewa Oyerinde, suggests for Type 3 & 4 hair, emulsifying conditioner throughout the hair when #scalpcooling helps to prevent further breakage.

https://t.co/U73an8BmW8

[Changing The Face Of Cancer Podcast @CTFOC_Podcast]

Clinical trials are the key to health equity.

The @tigerlily_foundation teaches the importance of clinical trials and why having no diversity in study groups means, black women are less likely to receive effective treatments and care.

Listen: https://t.co/U73an8BmW8

[Changing The Face Of Cancer Podcast @CTFOC_Podcast]

Patient advocates Maricia Cole and @Maimah describe how hair is a huge part of their identity – so ask why black women are assumed to handle hair loss better.

Even with options like wigs available, #scalpcooling discussions should always be initiated.

https://t.co/U73an8BmW8

[Changing The Face Of Cancer Podcast @CTFOC_Podcast]

New Episode!

Dermatologists Dr. Beth McLellan and Dr. Oyetewa Oyerinde – provide vital insight into where equity needs in cancer side-effect management are not being met, with real-life examples from a patient advocate.

Listen now: https://t.co/89Hv6cNlTG

[Changing The Face Of Cancer Podcast @CTFOC_Podcast]

Are patients of color receiving the same standard of cancer care as Caucasian patients?

@Maimah, Founder of @tigerlilycares, and this week's panel of experts address how we can ensure that all patients are provided with equitable and accessible care.

https://t.co/U73an8BULG

[Changing The Face Of Cancer Podcast @CTFOC_Podcast]

Clinical bias shouldn’t impact who is offered #scalpcooling.

Although the majority of #scalpcooling patients are female with breast cancer, this shouldn’t be used as the only eligibility criteria.

All patients should be given the choice.

Listen: https://t.co/U73an8BmW8